Back
Knight Therapeutics Stock Predictions
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
16
GUD.TO
Knight Therapeutics
Last Price:
5.28
Seasonality Move:
0.47%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Knight Therapeutics Stock Forecast
- Over the next 52 weeks, Knight Therapeutics has on average historically fallen by 0.9% based on the past 10 years of stock performance.
- Knight Therapeutics has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Knight Therapeutics Stock Undervalued?
The current Knight Therapeutics [GUD.TO] share price is $5.28. The Score for GUD.TO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal. - GUD.TO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Knight Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Knight Therapeutics has on average historically fallen by 0.9% based on the past 10 years of stock performance.
Knight Therapeutics Stock Rating
Sell
16
Knight Therapeutics (GUD.TO)
is a Sell
Is Knight Therapeutics overpriced?
- Knight Therapeutics has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Knight Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
TSX
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
gud-knight.com
52-Week Data
52-Week High:
6.23
52-Week Low:
5.07
Prediction Charts
Market Cap:
532.24M
Price in USD:
5.28
Volume:
68.65K
Beta:
0.53
Technical Analysis
SMA50:
5.48
SMA100:
5.62
SMA200:
5.65
52-Wk Change:
1.54%
Stock Predictions
-
Is Knight Therapeutics stock public?
Yes, Knight Therapeutics is a publicly traded company. -
What is the Knight Therapeutics stock quote today?
The Knight Therapeutics stock price is 5.28 USD today. -
How to buy Knight Therapeutics stock online?
You can buy Knight Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-22 | 5.27 | 5.29 | 5.32 | 5.25 |
| Nov-25 | 5.37 | 5.27 | 5.54 | 5.27 |
| Nov-26 | 5.27 | 5.29 | 5.34 | 5.22 |
| Nov-27 | 5.25 | 5.27 | 5.31 | 5.24 |
| Nov-28 | 5.22 | 5.22 | 5.29 | 5.22 |
| Nov-29 | 5.23 | 5.27 | 5.30 | 5.23 |
| Dec-2 | 5.24 | 5.34 | 5.34 | 5.24 |
| Dec-3 | 5.35 | 5.39 | 5.45 | 5.31 |
| Dec-4 | 5.37 | 5.36 | 5.40 | 5.30 |
| Dec-5 | 5.35 | 5.34 | 5.39 | 5.33 |
| Dec-6 | 5.34 | 5.33 | 5.37 | 5.30 |
| Dec-9 | 5.35 | 5.36 | 5.39 | 5.32 |
| Dec-10 | 5.30 | 5.33 | 5.36 | 5.30 |
| Dec-11 | 5.32 | 5.28 | 5.32 | 5.25 |
Knight Therapeutics Earnings
Knight Therapeutics Earnings Report: Per Share Knight Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Knight Therapeutics Forecast Revenue Growth
Knight Therapeutics Stock Analysis: Historical quarterly revenues per share for Knight Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.10 per share.
* Knight Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.